Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessCompaniesSun Pharma gets European Medicines Agency nod for Tobramycin

    Sun Pharma gets European Medicines Agency nod for Tobramycin

    The approval for the product was received by company's wholly owned subsidiary firm from the European Medicines Agency, Sun Pharmaceutical Industries said in a filing to BSE.

    February 16, 2017 / 18:35 IST
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Drug major Sun Pharmaceutical Industries today said its subsidiary has received approval for Tobramycin from the European Medicines Agency.

      The approval for the product was received by company's wholly owned subsidiary firm from the European Medicines Agency, Sun Pharmaceutical Industries said in a filing to BSE.

      The company and its subsidiaries continue to file multiple products across multiple countries on an on-going basis, Sun Pharma said while replying to a clarification on a news report sought by the exchange.

      "However this is not a material development for the company," it added.

      Shares of Sun Pharmaceutical Industries today closed at Rs 649.30 per scrip on BSE, up 4.31 per cent from its previous close.

      first published: Feb 16, 2017 06:24 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347